Cargando…

Of decrements and disorders: assessing impairments in neurodevelopment in prospective studies of environmental toxicant exposures

Prenatal and early life neurodevelopment is exquisitely sensitive to insult from environmental exposures. Identifying the effects of environmental toxicants on neurodevelopmental disorders is particularly important from a public health perspective because many of these exposures are modifiable and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagiv, Sharon K, Kalkbrenner, Amy E, Bellinger, David C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417302/
https://www.ncbi.nlm.nih.gov/pubmed/25609433
http://dx.doi.org/10.1186/1476-069X-14-8
_version_ 1782369352652161024
author Sagiv, Sharon K
Kalkbrenner, Amy E
Bellinger, David C
author_facet Sagiv, Sharon K
Kalkbrenner, Amy E
Bellinger, David C
author_sort Sagiv, Sharon K
collection PubMed
description Prenatal and early life neurodevelopment is exquisitely sensitive to insult from environmental exposures. Identifying the effects of environmental toxicants on neurodevelopmental disorders is particularly important from a public health perspective because many of these exposures are modifiable and may be targeted for intervention. Studying these associations in prospective cohort studies that measure quantitative, dimensional traits related to neurodevelopmental disorders, using standardized instruments such as psychometric tests or rating scales, mitigates many of the challenges that arise when studying clinically diagnosed disorders. We consider validity and feasibility impacts resulting from this design approach, including: 1) enhanced prospective exposure assessment with high quality environmental measures during developmentally relevant windows; 2) reduced bias because studies of continuous outcomes do not recruit cases and controls and are therefore not vulnerable to control selection bias; 3) enhanced statistical power because traits are measured on all individuals in the cohort and power is not limited by the number of cases; 4) reduced outcome misclassification because measuring quantitative traits avoids lumping together individuals with very heterogeneous phenotypes into one category. We use autism spectrum disorders (ASD) as an example to illustrate the advantages of this approach. Investigating the determinants of neurodevelopmental disorders – particularly modifiable determinants such as environmental toxicant exposures – is of great public health importance, given the apparent substantial rise of disorders like ASD over the past few decades. The use of prospective designs measuring quantitative, dimensional traits offers a powerful opportunity to provide important clues to the etiology of these disorders and is likely to accelerate our understanding of the role of environmental toxicant exposures as risk factors.
format Online
Article
Text
id pubmed-4417302
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44173022015-05-03 Of decrements and disorders: assessing impairments in neurodevelopment in prospective studies of environmental toxicant exposures Sagiv, Sharon K Kalkbrenner, Amy E Bellinger, David C Environ Health Commentary Prenatal and early life neurodevelopment is exquisitely sensitive to insult from environmental exposures. Identifying the effects of environmental toxicants on neurodevelopmental disorders is particularly important from a public health perspective because many of these exposures are modifiable and may be targeted for intervention. Studying these associations in prospective cohort studies that measure quantitative, dimensional traits related to neurodevelopmental disorders, using standardized instruments such as psychometric tests or rating scales, mitigates many of the challenges that arise when studying clinically diagnosed disorders. We consider validity and feasibility impacts resulting from this design approach, including: 1) enhanced prospective exposure assessment with high quality environmental measures during developmentally relevant windows; 2) reduced bias because studies of continuous outcomes do not recruit cases and controls and are therefore not vulnerable to control selection bias; 3) enhanced statistical power because traits are measured on all individuals in the cohort and power is not limited by the number of cases; 4) reduced outcome misclassification because measuring quantitative traits avoids lumping together individuals with very heterogeneous phenotypes into one category. We use autism spectrum disorders (ASD) as an example to illustrate the advantages of this approach. Investigating the determinants of neurodevelopmental disorders – particularly modifiable determinants such as environmental toxicant exposures – is of great public health importance, given the apparent substantial rise of disorders like ASD over the past few decades. The use of prospective designs measuring quantitative, dimensional traits offers a powerful opportunity to provide important clues to the etiology of these disorders and is likely to accelerate our understanding of the role of environmental toxicant exposures as risk factors. BioMed Central 2015-01-21 /pmc/articles/PMC4417302/ /pubmed/25609433 http://dx.doi.org/10.1186/1476-069X-14-8 Text en © Sagiv et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Sagiv, Sharon K
Kalkbrenner, Amy E
Bellinger, David C
Of decrements and disorders: assessing impairments in neurodevelopment in prospective studies of environmental toxicant exposures
title Of decrements and disorders: assessing impairments in neurodevelopment in prospective studies of environmental toxicant exposures
title_full Of decrements and disorders: assessing impairments in neurodevelopment in prospective studies of environmental toxicant exposures
title_fullStr Of decrements and disorders: assessing impairments in neurodevelopment in prospective studies of environmental toxicant exposures
title_full_unstemmed Of decrements and disorders: assessing impairments in neurodevelopment in prospective studies of environmental toxicant exposures
title_short Of decrements and disorders: assessing impairments in neurodevelopment in prospective studies of environmental toxicant exposures
title_sort of decrements and disorders: assessing impairments in neurodevelopment in prospective studies of environmental toxicant exposures
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417302/
https://www.ncbi.nlm.nih.gov/pubmed/25609433
http://dx.doi.org/10.1186/1476-069X-14-8
work_keys_str_mv AT sagivsharonk ofdecrementsanddisordersassessingimpairmentsinneurodevelopmentinprospectivestudiesofenvironmentaltoxicantexposures
AT kalkbrenneramye ofdecrementsanddisordersassessingimpairmentsinneurodevelopmentinprospectivestudiesofenvironmentaltoxicantexposures
AT bellingerdavidc ofdecrementsanddisordersassessingimpairmentsinneurodevelopmentinprospectivestudiesofenvironmentaltoxicantexposures